Transparency Market Research
Toxicology Drug Testing Market Revenue to Cross USD 55.9 billion by 2031, Growing at a CAGR of 5.5% Says Transparency Market Research
August 28, 2023 04:17 ET | Transparency Market Research
Wilmington, Delaware, United States, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global toxicology drug testing market is projected to flourish at a CAGR of 5.5% from...
AMR Logo.png
Global Allergy Diagnostics Market Is Expected to Generate $16.7 Billion by 2031: Allied Market Research
September 20, 2022 11:00 ET | Allied Market Research
Portland, OR, Sept. 20, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Allergy Diagnostics Market garnered $5.0 billion in 2021, and is estimated to...
Inotiv_Logo_CMYK.png
Inotiv, Inc. Continues to Expand Genetic Toxicology Offering with Support of GLP Assays at Rockville, MD, Location
July 26, 2022 08:33 ET | Inotiv, Inc.
WEST LAFAYETTE, Ind., July 26, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Color Logo.png
In Vitro Diagnostics Market is expected to grow from USD 109.70 billion in 2021 to USD 132.63 billion by 2029, at a CAGR of 2.6% during the forecast period 2022-2029 : GreyViews
July 21, 2022 06:15 ET | GreyViews
Pune India, July 21, 2022 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and Middle East...
MDx-3000
Hardy Diagnostics Now Offers the BioCode® MDx-3000
March 14, 2022 07:00 ET | Hardy Diagnostics
SANTA MARIA, Calif., March 14, 2022 (GLOBE NEWSWIRE) -- Hardy Diagnostics, a leader in manufactured and distributed microbiology products, is pleased to announce it is now the exclusive distributor...
Im The New England J
Im The New England Journal of Medicine veröffentlichte in-vitro-Daten zeigen, dass Seren von mit dem Pfizer-BioNTech COVID-19-Impfstoff geimpften Personen SARS-CoV-2 mit der Südafrika-Spike-Mutation neutralisieren
February 17, 2021 17:13 ET | BioNTech SE
New York, USA und Mainz, DEUTSCHLAND, 17. Februar 2021 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE: PFE) und BioNTech SE (Nasdaq: BNTX) gaben heute Ergebnisse einer in-vitro-Studie bekannt, die zusätzliche...
In Vitro Study Publi
In Vitro Study Published in The New England Journal of Medicine Demonstrates Sera from Individuals Immunized with the Pfizer-BioNTech COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant Spike Mutations
February 17, 2021 17:13 ET | BioNTech SE
New York, NY and Mainz, Germany, February 17, 2021 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced results from an in vitro study that provides additional...
Beroni Logo @ Dec 2019.png
Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Received CE Certification
December 21, 2020 08:30 ET | Beroni Group Limited
NEW YORK and SYDNEY, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the...
QUALITY Bizcapstacked.JPG
Business Capital Delivers Financing for Bay Area Medical Clinic
February 12, 2020 05:00 ET | Business Capital
SAN FRANCISCO, Feb. 12, 2020 (GLOBE NEWSWIRE) -- Business Capital structured and delivered approximately $6MM in senior secured loans for NOVA IVF, a clinic established in 1987, providing in vitro...
dnapicnew
Predictive Technology Group, Inc. (PRED) Announces Completion of Genotyping in Two Clinical Trials of ARTGuide™
February 20, 2018 09:00 ET | PREDICTIVE TECHNOLOGY GROUP, INC.
SALT LAKE CITY, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK:PRED) announces that Predictive Therapeutics, LLC, its wholly-owned subsidiary, completed a crucial...